Tudor Investment Corp’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,503
Closed -$222K 3304
2025
Q1
$222K Sell
12,503
-12,286
-50% -$265K ﹤0.01% 2802
2024
Q4
$531K Sell
24,789
-3,610
-13% -$87.8K ﹤0.01% 2192
2024
Q3
$887K Buy
28,399
+7,473
+36% +$186K ﹤0.01% 1697
2024
Q2
$325K Buy
+20,926
New +$253K ﹤0.01% 1985
2023
Q4
Sell
-11,506
Closed -$80.5K 2409
2023
Q3
$80.5K Buy
+11,506
New +$106K ﹤0.01% 2162
2023
Q2
Sell
-48,227
Closed -$441K 2475
2023
Q1
$441K Buy
+48,227
New +$617K 0.01% 1691
2021
Q4
Sell
-8,370
Closed -$530K 2446
2021
Q3
$530K Buy
8,370
+5,325
+175% +$406K 0.01% 1613
2021
Q2
$279K Sell
3,045
-10,318
-77% -$820K 0.01% 1376
2021
Q1
$910K Buy
+13,363
New +$1.04M 0.02% 883

Other funds holding CDNA

Tudor Investment Corp's CDNA Position: Q2 2025 in Review

Tudor Investment Corp sold out of CareDx (CDNA) in Q2 2025, closing a stake of 12,503 shares — an estimated $222K sold.

Tudor Investment Corp first reported a position in CDNA in Q1 2021 and held it in 9 quarters. The position peaked at $910K in Q1 2021. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Tudor Investment Corp reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 12,503 CareDx shares in Q2 2025, an estimated $222K.
  • Tudor Investment Corp first reported a position in CareDx in Q1 2021 and held it in 9 quarters.
  • Tudor Investment Corp's CareDx position peaked at $910K in Q1 2021.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.